摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-甲基-2-氧代-2H-色烯-5-羧酸甲酯 | 791856-36-5

中文名称
6-甲基-2-氧代-2H-色烯-5-羧酸甲酯
中文别名
——
英文名称
methyl 6-methylcoumarin-5-carboxylate
英文别名
Methyl 6-methyl-2-oxo-2H-chromene-5-carboxylate;methyl 6-methyl-2-oxochromene-5-carboxylate
6-甲基-2-氧代-2H-色烯-5-羧酸甲酯化学式
CAS
791856-36-5
化学式
C12H10O4
mdl
——
分子量
218.209
InChiKey
DWOHRDSIZYWIKC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    90-93 °C
  • 沸点:
    392.7±42.0 °C(Predicted)
  • 密度:
    1.274±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    52.6
  • 氢给体数:
    0
  • 氢受体数:
    4

安全信息

  • 海关编码:
    2932209090

SDS

SDS:024907bb0ae8219a2fc2fa7dbe9d698f
查看

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Convergent and rapid assembly of benzonaphthopyranone cores of chartreusin, chrymutasins and hayumicins
    摘要:
    A new methodology for the rapid regiospecific synthesis of benzonaphthopyranones has been developed, on the basis of a tactical extension of the Hauser-Kraus annulation. The prowess of the methodology has been illustrated by a short synthesis of chartarin (22b) and a facile entry to the chrymutasin scaffold (26). (C) 2004 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2004.08.142
  • 作为产物:
    参考文献:
    名称:
    Convergent and rapid assembly of benzonaphthopyranone cores of chartreusin, chrymutasins and hayumicins
    摘要:
    A new methodology for the rapid regiospecific synthesis of benzonaphthopyranones has been developed, on the basis of a tactical extension of the Hauser-Kraus annulation. The prowess of the methodology has been illustrated by a short synthesis of chartarin (22b) and a facile entry to the chrymutasin scaffold (26). (C) 2004 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetlet.2004.08.142
点击查看最新优质反应信息

文献信息

  • Synthetic Remodeling of the Chartreusin Pathway to Tune Antiproliferative and Antibacterial Activities
    作者:Nico Ueberschaar、Zhongli Xu、Kirstin Scherlach、Mikko Metsä-Ketelä、Tom Bretschneider、Hans-Martin Dahse、Helmar Görls、Christian Hertweck
    DOI:10.1021/ja4080024
    日期:2013.11.20
    of chartreusin derivatives. Pathway engineering of the chartreusin polyketide synthase, mutational synthesis, and molecular modeling were employed to successfully tailor the structure of chartreusin. For the synthesis of the aglycones, improved synthetic avenues to substituted coumarin building blocks were established. Using an engineered mutant, in total 11 new chartreusin analogs (desmethyl, methyl
    苯并酮类天然产物,如黄曲霉素、依沙霉素 A、gilvocarcin 和多癌素,代表了急需的抗癌疗法和抗生素的有效线索。由于用于改变其结构的合成协议是有限的,我们利用酶促混杂来生成一个聚焦的黄绿色衍生物库。黄绿色聚酮合酶的通路工程、突变合成和分子建模被用来成功地定制黄绿色的结构。对于苷元的合成,建立了替代香豆素结构单元的改进合成途径。使用工程突变体,总共有 11 种新的黄曲霉类似物(去甲基、甲基、乙基、乙烯基乙炔基、、羟基、甲氧基、和相应的 (1→2) abeo-chartreusins) 被生成并完全表征。他们的生物学评估揭示了环取代基对抗增殖和抗菌活性的意外影响。用蓝光照射乙烯基乙炔基取代的衍生物可提高对结肠直肠癌细胞系的抗增殖能力。相比之下,用氢取代甲基会导致细胞毒性急剧下降,但抗分枝杆菌活性显着增强。此外,黄绿色素的突变合成导致了在糖苷残基中未修饰的黄绿色素衍生物
  • Tandem annulation strategy for the convergent synthesis of benzonaphthopyranones: total synthesis of chartarin and O-methylhayumicinone
    作者:Sutapa Ray、Asit Patra、Dipakranjan Mal
    DOI:10.1016/j.tet.2008.01.039
    日期:2008.3
    A Hauser-initiated tandem annulation has been developed for the rapid regiospecific synthesis of benzonaphthopyranones via formation of two rings in one-pot operation. This strategy has been generalized with benzonaphthopyranones 26, 29, 32, and 35. It has also been employed in a short synthesis of chartarin (3) and O-methylhayumicinone (67).
    豪瑟(Hauser)引发的串联环已开发出来,用于通过一锅操作形成两个环来快速区域特异性合成苯并吡喃酮。这种策略已经被推广以benzonaphthopyranones 26,29,32,和35。它也已被用于沙丁鱼酯(3)和O-甲基干草umi酮(67)的短合成中。
  • NOVEL CHARTREUSIN ANALOGUES
    申请人:Leibniz-Institut Für Naturstoff-Forschung Und Infektionsbiologie, Hans Knöll Institut
    公开号:US20150197539A1
    公开(公告)日:2015-07-16
    The present invention relates to novel Chartreusin analogues of formula (I), pharmaceutical compositions comprising the same and to their use for the treatment of cancer and other diseases.
    本发明涉及公式(I)的新型Chartreusin类似物,包括其制备的药物组合物以及用于治疗癌症和其他疾病的方法。
  • US9522930B2
    申请人:——
    公开号:US9522930B2
    公开(公告)日:2016-12-20
查看更多